CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- 4 Grant or award Director acquired 10,500 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 3,780 shares at $3.86 ($14,609)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 7,420 shares at an average $3.30 ($24,462)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 48,203 shares at an average $3.17 ($152,917)
- 4 Open-market buy Director bought 10,000 shares at an average $2.50 ($24,985)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
Page 5 of 25 · 496 filings